超越纹:对肉毒毒素的使用进行全面审查
Journal of drugs in dermatology : JDD
|September 8, 2023
概括
肉毒神经毒素 (BoNT) 显示出超出化品用途的前景,一项审查发现了各种医疗领域的各种治疗应用. 需要进一步的研究,以探索其在治疗多种疾病方面的全部潜力.
科学领域:
- 神经学 神经学
- 皮肤病学 皮肤病学
- 胃肠病学 胃肠病学
- 眼科医生 眼科 眼科
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 妇科 妇科 妇科 妇科
- 心血管医学 心血管医学
背景情况:
- 肉毒神经毒素 (BoNT) 以其神经肌肉结节抑制作用而闻名.
- 它的应用已在化品皮肤病学中得到了很好的应用.
- 本综述分析了BoNT在治疗各种疾病方面的证据.
研究的目的:
- 系统地审查肉毒神经毒素 (BoNT) 的治疗应用.
- 分析BoNT超出化品和FDA批准的非美学用途的使用证据.
- 探索BoNT在各种医学专业领域的潜力.
主要方法:
- 进行了系统的文献审查.
- 包括2012年至2022年间发表的研究.
- 选择了58项涉及人类参与者和治疗性BoNT使用的研究.
主要成果:
- 确定了BoNT广泛的治疗用途.
- 这些发现超越了美学和现有的FDA批准的非美学应用.
- 证据支持BoNT在皮肤病,神经病和其他疾病中的有效性.
结论:
- 肉毒神经毒素 (BoNT) 是一种强大的神经毒素,具有多种FDA批准和研究用途.
- 该综述强调了多个医学领域的众多治疗应用.
- 建议进行更强大的研究,以进一步验证和扩展BoNT的多功能性.
更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
703
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
703
Skeletal Muscle Relaxants: Therapeutic Uses
511
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
511
Cholinergic Antagonists: Therapeutic Uses
775
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
775
Direct-Acting Cholinergic Agonists: Therapeutic Uses
790
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
790
Skeletal Muscle Relaxants: Adverse Effects
398
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
398
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
455
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
455


